Automated 2′-O-Methyl RNA Probe Detection With Tyramide Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing RNA detection technologies struggle with sensitivity and specificity, particularly for short microRNA targets, due to limited target sequence length, stability issues, and the need for significant amplification, which are not adequately addressed by current methods.

Innovation Solution

The use of 2′-O-methyl RNA oligonucleotide probes labeled with detectable moieties for in-situ hybridization, combined with tyramide signal amplification, enables sensitive and specific detection of RNA molecules, including microRNA, in formalin-fixed paraffin-embedded tissue samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional RNA detection methods are used, then detection can be performed, but sensitivity is insufficient for short microRNA targets

Engineering Contradiction:
Improvedetection sensitivityVSAvoidtarget sequence length
Core Design Contradiction:
Measurement precisionVSLength of moving object

Solution Approach 1:

The patent implements nested amplification where tyramide signal amplification is combined with branched-DNA amplification. The tyramide system first amplifies the signal from the probe-target hybrid, creating multiple tyramide molecules per probe. Then branched-DNA amplification further amplifies this signal, creating a nested amplification architecture that achieves sufficient signal for detecting short microRNA targets

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The patent changes the chemical structure of the probe by using 2′-O-methyl RNA oligonucleotides instead of conventional RNA or DNA probes. This parameter change in probe chemistry provides enhanced binding affinity to RNA targets and increased stability, thereby improving detection sensitivity for short microRNA sequences

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If probe length is increased to improve specificity, then target specificity improves, but short microRNA targets cannot be detected

Engineering Contradiction:
Improvetarget specificityVSAvoidprobe length
Core Design Contradiction:
Measurement precisionVSLength of moving object

Solution Approach 1:

The patent changes the chemical composition and structure of the probe by using 2′-O-methyl RNA oligonucleotides. This parameter change provides enhanced binding affinity and specificity to RNA targets while maintaining the ability to work with short probe lengths appropriate for microRNA detection, resolving the contradiction between probe length and target specificity

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If RNA probes are used for detection, then detection sensitivity improves, but nuclease degradation reduces reliability

Engineering Contradiction:
Improvedetection sensitivityVSAvoidprobe stability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent changes the chemical structure of the probe by incorporating 2′-O-methyl modifications into the RNA oligonucleotide. This parameter change confers nuclease resistance to the probe while maintaining its ability to hybridize to RNA targets with high sensitivity, thereby resolving the contradiction between detection sensitivity and probe stability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite probe structure by combining RNA bases with 2′-O-methyl sugar modifications. This composite material approach provides both the hybridization capability of RNA and the nuclease resistance of modified sugars, achieving both high detection sensitivity and probe stability

Inventive Principle:
Principle #40Composite materials

4Measurement precision

If extensive amplification is used to detect short targets, then detection sensitivity improves, but device complexity increases

Engineering Contradiction:
Improvedetection sensitivityVSAvoidamplification system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent implements nested amplification where tyramide signal amplification is combined with branched-DNA amplification. This nested architecture provides extensive amplification capability while organizing the complexity in a structured, multi-layered system that can be integrated into automated platforms

Inventive Principle:
Principle #7Nested doll (Nesting)

5Adaptability or versatility

If manual detection methods are used, then flexibility is maintained, but automation capability is limited

Engineering Contradiction:
Improvedetection flexibilityVSAvoidautomation capability
Core Design Contradiction:
Adaptability or versatilityVSExtent of automation

Solution Approach 1:

The patent develops a universal detection platform that can detect various RNA targets including microRNA, mRNA, and non-coding RNA using the same 2′-O-methyl RNA probe technology and amplification system. This multi-functional approach enables automation while maintaining flexibility across different target types

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides enhanced binding affinity and nuclease resistance, allowing for robust and automated detection of RNA species, including microRNA, with improved sensitivity and preservation of cell morphology.

Implementation Method 1

contacting the sample with a labeled synthetic 2'-O-methyl oligonucleotide probe under conditions sufficient that the probe hybridizes to the target RNA in the sample

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

combined with tyramide signal amplification, enables sensitive and specific detection of RNA molecules

Methodology Applied
Scientific EffectTyramide signal amplification:

Data Source

PatentUS12398419B2Automated RNA detection using labeled 2′-O-methyl RNA oligonucleotide probes and signal amplification systems
Publication Date: 2025.08.26 VENTANA MEDICAL SYSTEMS INC
  • US12398419B2 patent drawing
  • US12398419B2 patent drawing
  • US12398419B2 patent drawing

AI summary

Disclosed herein are methods and compositions for detecting differential expression of certain miRNAs in cancer cells or their surrounding normal tissues in the tumor microenvironment. The disclosure describes an automated, highly sensitive and specific method for detection of any cellular RNA molecule, including microRNA, messenger RNA and non-coding RNA. The technology includes probe design as well as probe use in an automated fashion for detection of RNA molecules in formalin-fixed paraffin-embedded tissue (FFPET) samples.